title: Polymorphic ventricular tachycardia in patients with vasospastic angina--clinical and electrocardiographic characteristics and long-term outcome.
abstract: There have been few clinical studies exploring the characteristics of spontaneous polymorphic ventricular tachycardia (VT) during a vasospastic angina attack. During a 4-year recruitment period, Holter ECG recordings were monitored for 42+/-24 h during a drug-free period in 60 consecutive patients with vasospastic angina (VSA) and of these, 8 patients had at least one episode of polymorphic VT during monitoring. Ischemic ST segment elevation was immediately preceded the spontaneous polymorphic VT in all 8 patients, 4 of whom had silent coronary vasospasm. Immediately before the onset of polymorphic VT, both R-on-T and long-short sequences were observed in 4 of the 8 patients and ST wave alternans were recorded in 2 patients. VT exhibited a pattern of torsade de pointes in 4 of the 8 patients. Five patients underwent electrophysiologic testing during a drug-free asymptomatic phase, and polymorphic VT was induced in 2 of the 5 patients, with one developing ventricular fibrillation. During a follow-up period of 73+/-17 months, there was a significant difference in the incidence of sudden death between patients with and without VT (2/8 cases [25%] vs 0/52 [0%]; p<0.01). Thus, vasospastic attacks, even if asymptomatic, that immediately precede the development of polymorphic VT may be associated with a repolarization abnormality and an increased risk of sudden death.
authors.affiliation: Department of Cardiology, Yokohama Minami Kyosai Hospital, Kanagawa, Japan. nisizaki-ind@umin.ac.jp
authors.forename: M
authors.initials: M
authors.lastname: Nishizaki
authors.forename: M
authors.initials: M
authors.lastname: Arita
authors.forename: H
authors.initials: H
authors.lastname: Sakurada
authors.forename: M
authors.initials: M
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Ashikaga
authors.forename: N
authors.initials: N
authors.lastname: Yamawake
authors.forename: F
authors.initials: F
authors.lastname: Numano
authors.forename: M
authors.initials: M
authors.lastname: Hiraoka
mesh_terms: D000109:Acetylcholine / Q000008:administration & dosage / Q000494:pharmacology; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000150:complications* / Q000401:mortality; D017023:Coronary Angiography; D003329:Coronary Vasospasm / Q000139:chemically induced / Q000150:complications* / Q000401:mortality; D016757:Death, Sudden, Cardiac / Q000209:etiology; D015716:Electrocardiography, Ambulatory; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D017180:Tachycardia, Ventricular / Q000209:etiology* / Q000401:mortality / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D000109:Acetylcholine